Source link : https://newshealth.biz/health-news/ultra-low-dose-immunotherapy-may-benefit-cancer-patients-in-low-resource-countries/
CHICAGO — Triple oral metronomic chemotherapy combined with ultra-low-dose immunotherapy (TMC-I) may be a promising first-line treatment for patients in low-resource countries with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC), an open-label phase III trial suggested. TMC-I extended median overall survival (OS), the primary endpoint, to 10.3 months from 6.2 months in […]
The post Ultra-Low-Dose Immunotherapy May Benefit Cancer Patients in Low-Resource Countries first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-02 20:26:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8